In an IND-enabling study, intranasal COVI-AMG nAb (STI-2099 or COVI-DROPSTM) very early on decreased COVID-19 disease severity and shortened the duration of the disease in infected hamsters, and ...

PRESS RELEASE GlobeNewswire Aug. 19, 2020, 09:00 AM IND filing today for STI-1499 (COVI-GUARD™) for hospitalized COVID-19 patients.

In testing conducted to date, COVI-STIX has provided results within 15 minutes, with positive detection as quickly as two minutes for patient samples with high viral load.

--Sorrento Therapeutics, Inc. today announced that the Mexican Comisión Federal para la Protección contra Riesgos Sanitarios, the health regulatory authority for Mexico, has listed COVI-STIX on ...